Montelukast D6 sodium
| Product Name | Montelukast D6 sodium |
|---|---|
| Alternate Names | Montelukast Stable Isotopes, Stable Isotopes of Montelukast |
| CAT No. | CS-O-03176 |
| CAS No. | 151767-02-1 (Unlabelled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 614.20 g/mol |
| Mol. For. | C₃₅H₂₉D₆ClNNaO₃S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Montelukast |
| Purity | 95% |
| Therapeutic | Anti-Asthma / COPD |
| Smileys | [O-]C(CC1(CC1)CS[C@@H](C2=CC(/C=C/C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)CCC(C=CC=C5)=C5C(O)(C([2H])([2H])[2H])C([2H])([2H])[2H])=O.[Na+] |
| Canonical Smiles | CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)[O-])O.[Na+] |
| InchIKey | LBFBRXGCXUHRJY-HKHDRNBDSA-M |
| Inchl | InChI=1S/C35H36ClNO3S.Na/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29;/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39);/q;+1/p-1/b15-10+;/t32-;/m1./s1 |
| IUPAC | sodium;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Montelukast D6 sodium is a deuterated analog of the anti-inflammatory drug Montelukast sodium, which is commonly used in the treatment of asthma and allergic rhinitis. The deuterated form, Montelukast D6 sodium, is used primarily in pharmacokinetic studies to understand the metabolism and disposition of the drug in the body.
Montelukast D6 sodium is a leukotriene receptor antagonist that works by blocking the action of leukotrienes, which are chemicals produced by the body in response to allergens. These chemicals cause inflammation and constriction of the airways, leading to asthma symptoms such as wheezing, shortness of breath, and chest tightness. By blocking the action of leukotrienes, Montelukast D6 sodium helps to reduce inflammation and improve breathing in people with asthma and allergic rhinitis.
Chemically, Montelukast D6 sodium is a white to off-white powder that is soluble in water and slightly soluble in ethanol. It has a molecular weight of 529.57 g/mol and a chemical formula of C35H32D6N4NaO3S. The deuterated form of the drug is identical to the non-deuterated form in terms of its pharmacological properties, but it is distinguishable from the non-deuterated form using mass spectrometry techniques.
In conclusion, Montelukast D6 sodium is an important tool in pharmacokinetic studies of Montelukast sodium, and its use helps to better understand the metabolism and disposition of the drug in the body.
Get an Instant Quote
Related Compounds
Montelukast D6 | Methoxy-d3 Montelukast Methyl Ester-d3 |